MAD1L1 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
-
- Antigène Voir toutes MAD1L1 Protéines
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
- Type de proteíne
- Recombinant
- Attributs du protein
- Transcript Variant 2
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette MAD1L1 protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human MAD1L1 (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product MAD1L1 Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
- Autre désignation
- Mad1l1 (MAD1L1 Produits)
- Synonymes
- MAD1 Protein, PIG9 Protein, TP53I9 Protein, TXBP181 Protein, AI173502 Protein, AW550425 Protein, Mad1 Protein, zgc:56571 Protein, MAD1-like protein 1 Protein, mitotic arrest deficient 1 like 1 Protein, MAD1 mitotic arrest deficient like 1 Protein, MAD1 mitotic arrest deficient 1-like 1 Protein, deafness, autosomal recessive 19 Protein, MAD1L1 Protein, Mad1l1 Protein, mad1l1 Protein, DFNB19 Protein
- Sujet
- MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Alternative splicing results in multiple transcript variants.
- Poids moléculaire
- 82.9 kDa
- NCBI Accession
- NP_001013858
- Pathways
- M Phase
-